Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: A retrospective chart review study

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 1815-1822

  Davis, Keith L ^a   Wei, Wenhui ^b   Meyers, Juliana L ^a   Kilpatrick, Brett S ^c   Pandya, Naushira ^d  

^a RTI HEALTH SOLUTIONS   (United States)

^b SANOFI   (France)

^c AnalytiCare   (United States)

^d Nova Southeastern University   (United States)

Author keywords

Insulin detemir; Insulin glargine; Long term care; NPH insulin; Nursing homes; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA; GLARGINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LONG ACTING INSULIN;

AGED; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; DAILY LIFE ACTIVITY; DRUG DELIVERY DEVICE; DRUG EFFICACY; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INJECTABLE PEN DEVICE; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING HOME PATIENT; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; VERY ELDERLY; WOUND INFECTION; BLOOD; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DRUG COMBINATION; DRUG UTILIZATION; HOME FOR THE AGED; NURSING HOME; RETROSPECTIVE STUDY; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMES FOR THE AGED; HUMANS; HYPOGLYCEMIA; INJECTIONS, SUBCUTANEOUS; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84908258721     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S65411     Document Type: Article

References (21)

1. Haas LB. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities. J Am Med Dir Assoc. 2007; 8(8):502–510.
2. American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Suppl 1):S11–S63.
3. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–2664.
4. Fravel MA, McDanel DL, Ross MB, Moores KG, Starry MJ. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm. 2011;68(6):500–509.
5. American Medical Directors Association [webpage on the Internet]. Columbia, MD: Clinical practice guidelines in the long term care setting: diabetes management; 2010. Available from: http://www.amda.com/tools/guidelines.cfm#diabetes. Accessed March 20, 2014.
6. Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging. 2001;18(1):31–44.
7. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120(7):563–567.
8. Pandya N, Thompson S, Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. J Am Med Dir Assoc. 2008;9(9): 663–669.
9. Feldman SM, Rosen R, DeStasio J. Status of diabetes management in the nursing home setting in 2008: a retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc. 2009;10(5): 354–360.
10. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–1379.
11. Pandya N, Wei W, Meyers JL, Kilpatrick BS, Davis KL. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus. J Am Geriatr Soc. 2013;61(12):2103–2110.
12. Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health Syst Pharm. 2004;61(15):1611–1614.
13. Nau KC, Lorenzetti RC, Cucuzzella M, Devine T, Kline J. Glycemic control in hospitalized patients not in intensive care: beyond sliding-scale insulin. Am Fam Physician. 2010;81(9):1130–1135.
14. Goykhman S, Drincic A, Desmangles JC, Rendell M. Insulin glargine: a review 8 years after its introduction. Expert Opin Pharmacother. 2009; 10(4):705–718.
15. Davis SN, Wei W, Garg S. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Endocr Pract. 2011;17(6): 845–852.
16. Xie L, Wei W, Pan C, Du J, Baser O. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Adv Ther. 2011;28(11):1000–1011.
17. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl):S265–S280.
18. Rizvi AA. Management of diabetes in older adults. Am J Med Sci. 2007; 333(1):35–47.
19. Feil DG, Rajan M, Soroka O, Tseng CL, Miller DR, Pogach LM. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011; 59(12):2263–2272.
20. Bellissimo JL, Holt RM, Maus SM, Marx TL, Schwartz FL, Shubrook JH. Impact of activity participation and depression on glycemic control in older adults with diabetes: glycemic control in nursing homes. Clin Diabetes. 2011;29(4):139–144.
21. Semiz S, Dujic T, Causevic A. Pharmacogenetics and personalized treatment of type 2 diabetes. Biochem Med (Zagreb). 2013;23(2): 154–171.